Efficacy and Safety of WCFA19 (<i>Weissella confusa</i> WIKIM51) in Reducing Body Fat in Overweight and Obese Adultsopen access
- Authors
- Sun, Hwayeon; Shin, Jinyoung; Kim, Min-ji; Bae, Sunghwan; Lee, Nicole Dain; Yoo, Byungwook
- Issue Date
- May-2024
- Publisher
- MDPI
- Keywords
- probiotics; Weissella confusa WIKIM51; Lactobacillus fermentum; kimchi; obesity; overweight; anti-obesity
- Citation
- JOURNAL OF CLINICAL MEDICINE, v.13, no.9
- Journal Title
- JOURNAL OF CLINICAL MEDICINE
- Volume
- 13
- Number
- 9
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/26432
- DOI
- 10.3390/jcm13092559
- ISSN
- 2077-0383
- Abstract
- Background: WCFA19 (Weissella confusa WIKIM51), found during the fermentation of kimchi, is known for its inhibitory effects on body weight and body fat. This study looked at the impact of WCFA19 isolated from dandelion kimchi on weight loss in overweight and obese adults that are otherwise healthy. Methods: This study was conducted as a multicenter, double-blind, randomized, placebo-controlled study with 104 overweight and obese subjects. Subjects were randomized evenly into the test group (WCFA19, 500 mg, n = 40) or control group (n = 34) for 12 weeks from 14 June 2021 to 24 December 2021. Effects were based on DEXA to measure changes in body fat mass and percentage. Results: Among the 74 subjects analyzed, WCFA19 oral supplementation for 12 weeks resulted in a significant decrease in body fat mass of 633.38 +/- 1396.17 g (p = 0.0066) in overweight and obese individuals in the experimental group. The control group showed an increase of 59.10 +/- 1120.57 g (p = 0.7604), indicating a statistically significant difference between the two groups. There was also a statistically significant difference (p = 0.0448) in the change in body fat percentage, with a decrease of 0.41 +/- 1.22% (p = 0.0424) in the experimental group and an increase of 0.17 +/- 1.21% (p = 0.4078) in the control group. No significant adverse events were reported. Conclusions: Oral supplementation of 500 mg of WCFA19 for 12 weeks is associated with a decrease in body weight, particularly in body fat mass and percentage.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Family Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.